I think you are right, I feel the BOD is quite amused that the investors hang on the meaning of every single word. However, there is good reason and much motivation to pay attention to every word. Many times I feel they are being sloppy, other times i feel they really can't be held to a timeline that is dependent on the FDA.

As for adding a little cushion to timelines, that works if the task is well defined. If it is when the FDA is getting back to you, they could get back with a request that adds 6 months to your 2 week timeline. there is no cushion amount that covers that.

The best procedure I have found is to explain how the timeline is developed and how it can change with the likelihood of those changes occurring. It is easy to set expectations when the process is laid out, something Nader could do better with. My opinion is that Nader assumes we all know things can change and that his timelines are based on the available info that day, which will change for sure.